Showing results (111-120 of 173) with videos related to
Sort By:
Pageof 18
Journal of Psychoactive Drugs|April 1, 1994
Retention of patients who entered methadone maintenance via an interim methadone clinicP Friedman, D C Des Jarlais, N P Peyser, et al.International Journal of STD & AIDS|September 1, 2006
Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug usersZ P Vassilev, H Hagan, A Lyubenova, et al.Journal of Substance Abuse Treatment|April 18, 2001
Drug use, HIV-related risk behaviors and dropout status of new admissions and re-admissions to methadone treatmentS Deren, M F Goldstein, D C Des Jarlais, et al.Journal of Viral Hepatitis|September 13, 2003
Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in ItalyG L Quaglio, F Lugoboni, B Pajusco, et al.Journal of Substance Abuse Treatment|June 20, 1998
Organizational issues in conducting tuberculosis screening at a syringe exchange programD Paone, D C Perlman, M P Perkins, et al.Journal of Substance Abuse Treatment|January 1, 1997
"Shotgunning" as an illicit drug smoking practiceD C Perlman, M P Perkins, D Paone, et al.AIDS and Behavior|November 1, 2011
Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in EstoniaA Uusküla, J M McMahon, M Kals, et al.Advances in Preventive Medicine|July 11, 2013
30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject DrugsD C Des Jarlais, S Pinkerton, H Hagan, et al.The Journal of Infectious Diseases|August 1, 1990
Contrasting prevalence of delta hepatitis markers in parenteral drug abusers with and without AIDSM J Kreek, D C Des Jarlais, C L Trepo, et al.American Journal of Public Health|December 8, 1998
Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996D C Des Jarlais, T Perlis, S R Friedman, et al.Pageof 18